@article{article, title  = {{Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC) (Trial in Progress)}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/s0302-2838(22)00414-6 }},

 year = {{2022}},

 month = {{2}},

 author = {{Kamat AM and Steinberg G and Inman B and Kates M and Uchio E and Porten S and Rouperet M and Palou J and Catto J and Kulkarni GS and Powles T et al}},

 doi = {{10.1016/s0302-2838(22)00414-6}},

 volume = {{81}},

 journal = {{European Urology}},

 pages = {{S507-S507}},

 note = {{Accessed on 2024/12/22}}}